Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
Gene expression profiling of the response to interferon Beta in epstein-barr-transformed and primary B cells of patients with multiple sclerosis.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold.
Microglia: Multitasking Specialists of the Brain.
Managing patients with neurologic disorders who participate in sports activities.
Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors.
Evaluating sex hormone levels in reproductive age women with multiple sclerosis and their relationship with disease severity.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
What place for {blacktriangledown}cannabis extract in MS?
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.
JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression.
Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35-55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice.
Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.
Toll like receptors: a new hope on the horizon to treat multiple sclerosis.
A multicomponent T2 relaxometry algorithm for myelin water imaging of the brain.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »